Jacaranda, a member of Bignoniaceae family, contains 49 species around the world that are native to Central and South America and the Caribbean. Very few additional data are available on the pharmacological evidences from genus Jacaranda. The following article gives a critical assessment of the literature to date, aims to show that the pharmaceutical potential of this genus has been underestimated, and deserves closer attention.